- Home
- ABOS vs CFSB Comparison
ABOS vs CFSB Comparison
Compare ABOS & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- CFSB
- Stock Information
- Founded
- ABOS 1996
- CFSB 1889
- Country
- ABOS United States
- CFSB United States
- Employees
- ABOS N/A
- CFSB N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- CFSB Major Banks
- Sector
- ABOS Health Care
- CFSB Finance
- Exchange
- ABOS Nasdaq
- CFSB Nasdaq
- Market Cap
- ABOS 103.6M
- CFSB 92.5M
- IPO Year
- ABOS 2021
- CFSB N/A
- Fundamental
- Price
- ABOS $1.88
- CFSB $14.12
- Analyst Decision
- ABOS Strong Buy
- CFSB
- Analyst Count
- ABOS 3
- CFSB 0
- Target Price
- ABOS $8.00
- CFSB N/A
- AVG Volume (30 Days)
- ABOS 410.3K
- CFSB 4.1K
- Earning Date
- ABOS 11-11-2025
- CFSB 10-28-2025
- Dividend Yield
- ABOS N/A
- CFSB N/A
- EPS Growth
- ABOS N/A
- CFSB N/A
- EPS
- ABOS N/A
- CFSB N/A
- Revenue
- ABOS N/A
- CFSB $7,612,000.00
- Revenue This Year
- ABOS N/A
- CFSB N/A
- Revenue Next Year
- ABOS N/A
- CFSB N/A
- P/E Ratio
- ABOS N/A
- CFSB N/A
- Revenue Growth
- ABOS N/A
- CFSB N/A
- 52 Week Low
- ABOS $0.86
- CFSB $6.41
- 52 Week High
- ABOS $3.36
- CFSB $14.24
- Technical
- Relative Strength Index (RSI)
- ABOS 67.95
- CFSB 54.04
- Support Level
- ABOS $1.67
- CFSB $14.06
- Resistance Level
- ABOS $1.86
- CFSB $14.14
- Average True Range (ATR)
- ABOS 0.16
- CFSB 0.06
- MACD
- ABOS 0.06
- CFSB -0.01
- Stochastic Oscillator
- ABOS 73.86
- CFSB 54.55
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.